MetaVia Inc.

NASDAQ: MTVA · Healthcare · Biotechnology

PublicHQ Cambridge, MA · MiddlesexCIK 0001638287Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 26DQ —GM —SS 37

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, balance-sheet leverage · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$13.0M

Employees

Market cap

$3.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$13.0M-$13.0M2025

Operating income-$13.7M-$13.7M2025

Total assets$11.1M$11.1M2025

Liabilities$5.8M$5.8M2025

Equity$5.3M$5.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

MetaVia Inc. earned -$13.0M in FY2025 net income.

Peers · Healthcare

QHSLab, Inc.69B Promino Nutritional Sciences Inc29D nDatalyze Corp.47D Polomar Health Services, Inc.28D

Neighbors

Middlesex →

GE Vernova Inc.$38.1B63C Thermo Fisher Scientific Inc.$44.6B86A Analog Devices, Inc.$11.0B87A The TJX Companies, Inc.$60.4B85A Boston Scientific Corporation$20.1B88A Alnylam Pharmaceuticals, Inc.$3.7B79B+

Key facts

CEOHyung Heon Kim

SectorHealthcare

IndustryBiotechnology

HeadquartersCambridge, MA

ExchangeNASDAQ: MTVA

Employees9

IPO date2016-08-05

Latest filings

8-K2026-07-09 8-K2026-07-02 8-K2026-06-08 8-K2026-06-08 8-K2026-05-27 8-K2026-05-18 8-K2026-05-14 10-Q2026-05-14

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.